| Understanding patient perspectives on medication adherence in asthma: a targeted review of qualitative studies S Amin, M Soliman, A McIvor, A Cave, C Cabrera Patient preference and adherence, 541-551, 2020 | 65 | 2020 |
| Usage patterns of short-acting β2-agonists and inhaled corticosteroids in asthma: a targeted literature review S Amin, M Soliman, A McIvor, A Cave, C Cabrera The Journal of Allergy and Clinical Immunology: In Practice 8 (8), 2556-2564. e8, 2020 | 43 | 2020 |
| Systematic literature review of the epidemiology of advanced prostate cancer and associated homologous recombination repair gene alterations N Shore, L Oliver, I Shui, A Gayle, OY Wong, J Kim, S Payne, S Amin, ... The Journal of urology 205 (4), 977-986, 2021 | 22 | 2021 |
| Natural History and Disease Burden of Neurofibromatosis Type 1 with Plexiform Neurofibromas: A Systematic Literature Review SSS C Merriman, X Yang, M Juniper, S Amin, HK Yoo Adolescent Health, Medicine and Therapeutics 12, 55-56, 2021 | 21 | 2021 |
| Real-world observational study on the characteristics and treatment patterns of allergic asthma patients receiving omalizumab in Canada JK Lee, S Amin, M Erdmann, A Kukaswadia, J Ivanovic, A Fischer, ... Patient preference and adherence, 725-735, 2020 | 11 | 2020 |
| Epidemiological and clinical burden associated with plexiform neurofibromas in pediatric neurofibromatosis type-1 (NF-1): a systematic literature review I Iheanacho, HK Yoo, X Yang, S Dodman, R Hughes, S Amin Neurological Sciences 43 (2), 1281-1293, 2022 | 8 | 2022 |
| Patients' and oncologists' preferences for second-line maintenance PARP inhibitor therapy in epithelial ovarian cancer RL Stone, MJ Cambron-Mellott, K Beusterien, MC Maculaitis, S Ritz, ... Future Oncology 18 (4), 491-503, 2022 | 5 | 2022 |
| Clinical and humanistic burden among pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma in the USA X Yang, HK Yoo, S Amin, WY Cheng, S Sundaresan, L Zhang, MS Duh Child's Nervous System 38 (8), 1513-1522, 2022 | 4 | 2022 |
| Health-related quality of life scores of metastatic pancreatic cancer patients responsive to first line chemotherapy compared to newly derived EORTC QLQ-C30 reference values S Amin, S Joo, S Nolte, HK Yoo, N Patel, HF Byrnes, S Costa-Cabral, ... BMC cancer 22 (1), 563, 2022 | 4 | 2022 |
| The impact of a cancer diagnosis on worker productivity: Results from a survey of cancer patients and caregivers. SG May, K Chiu, JP MacEwan, K Bognar, D Peneva, L Zhao, C Yong, ... Journal of Clinical Oncology 38 (29_suppl), 144-144, 2020 | 4 | 2020 |
| Burden among caregivers of pediatric patients with neurofibromatosis type 1 (NF1) and Plexiform Neurofibroma (PN) in the United States: a cross-sectional study X Yang, HK Yoo, S Amin, WY Cheng, S Sundaresan, L Zhang, MS Duh Neurology and Therapy 11 (3), 1221-1233, 2022 | 3 | 2022 |
| Estimating Productivity Loss from Breast and Non–Small-Cell Lung Cancer among Working-Age Patients and Unpaid Caregivers: A Survey Study Using the Multiplier Method K Chiu, JP MacEwan, SG May, K Bognar, D Peneva, LM Zhao, C Yong, ... MDM Policy & Practice 7 (2), 23814683221113846, 2022 | 3 | 2022 |
| Benefit-risk trade-offs in treatment choice in advanced HER2 negative breast cancer: patient and oncologist perspectives S Amin, SM Tolaney, MJ Cambron-Mellott, K Beusterien, MC Maculaitis, ... Future Oncology 18 (16), 1927-1941, 2022 | 3 | 2022 |
| Real-world treatment patterns among patients with metastatic castration-resistant prostate cancer (mCRPC) in the US. E Malangone-Monaco, W Li, V Noxon, S Jiang, S Amin, S Ghate, ... Journal of Clinical Oncology 40 (6_suppl), 49-49, 2022 | 3 | 2022 |
| Health-related quality of life of patients with metastatic pancreatic cancer: a systematic literature review HK Yoo, N Patel, S Joo, S Amin, R Hughes, R Chawla Cancer Management and Research, 3383-3403, 2022 | 3 | 2022 |
| Reference values for EORTC QLQ-C30, for metastatic pancreatic cancer (mPC): Enhancing the interpretation of HRQoL scores in the POLO trial. HL Kindler, S Amin, S Joo, N Patel, HK Yoo, C Johnson, H Byrnes, ... Journal of Clinical Oncology 39 (3_suppl), 393-393, 2021 | 1 | 2021 |
| 661P Real-world treatment (Tx) patterns of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the US N Shore, F Laliberté, R Ionescu-Ittu, A Gayle, S Amin, L Yang, S Payne, ... Annals of Oncology 31, S534-S535, 2020 | 1 | 2020 |
| 641P Real-world patterns of genomic testing in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) N Shore, R Ionescu-Ittu, L Yang, F Laliberté, S Payne, A Gayle, S Amin, ... Annals of Oncology 31, S526-S527, 2020 | 1 | 2020 |
| Treatment Patterns and Outcomes for Patients with Newly Diagnosed Multiple Myeloma Post-Stem Cell Transplantation Who Received Lenalidomide As First Line Maintenance Therapy … R Vij, S Amin, J Gu, TS Marshall, S Fish, S Dhanasiri, G Hernandez, ... Blood 142, 3786, 2023 | | 2023 |
| Clinical Outcomes in Real-World Patients (RW) with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM): A Retrospective Study Using Electronic Health Records … HC Lee, S Jagannath, D Dhanda, T Acheampong, P Patwardhan, ... Blood 142, 3775, 2023 | | 2023 |
Andrew McIvorFIRH, McMaster UniversityVerified email at mcmaster.ca
